O
RNAM

OrbiMed’s Avidity Biosciences RNAM Stock Holding History

OrbiMed’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,000
Closed -$4.59M – 135
2024
Q3 		$4.59M Buy
+100,000
New +$4.34M 0.08% 100

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

OrbiMed's RNAM Position: Q1 2026 in Review

OrbiMed sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 619,530 shares — an estimated $44.7M sold.

OrbiMed first reported a position in RNAM in Q2 2020 and held it in 10 quarters. The position peaked at $71.4M in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • OrbiMed reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • OrbiMed sold 619,530 Avidity Biosciences shares in Q1 2026, an estimated $44.7M.
  • OrbiMed first reported a position in Avidity Biosciences in Q2 2020 and held it in 10 quarters.
  • OrbiMed's Avidity Biosciences position peaked at $71.4M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.